Font Size: a A A
Keyword [Major Adverse Cardiovascular Events]
Result: 81 - 100 | Page: 5 of 9
81. Study Of Pharmacokineticsand Pharmacodynamicsof Clopidogrel And Outcomes Of Patients Undergoing PCI
82. New Genetic Variants Associated With Major Adverse Cardiovascular Events In Patients With Acute Coronary Syndromes And Treated With Clopidogrel And Aspirin
83. The Correlation Between MTHFR And CYP2C19 Gene Polymorphism And Coronary Heart Disease In Han Population In Guangdong Province
84. Strategies And Optimal Timing Of Percutaneous Revascularization For Patients With ST-segment Elevation Myocardial Infarction And Multivessel Coronary Artery Disease
85. Correlation Between The Epicardial Fat Thickness And Adverse Cardiovascular Event In Acute Coronary Syndrome
86. PSTEMI Model: Exploration Of A New Perioperative Risk Evaluation Model In Patients Treated With Primary Percutaneous Coronary Intervention
87. Role Of The Chest Pain Center In Treatment Of Patients With NSTE ACS
88. Myocardial Protective Effect Of Oxycodone Prolonged-release Tablets On Patients With Acute ST-segment Elevation Myocardial Infarction Undergoing Primary PCI
89. Combined Value Of White Blood Cell And Total Bilirubin On Predicting MACE In STEMI
90. The Predictive Value Of MHR And MPV For The Major Adverse Cardivascular Events In Patients With AMI Undergoing PCI
91. The Value Of Advanced Glycation End Products In Predicting Major Adverse Cardiovascular Events:Meta Analysis
92. Effect Of Delayed PCI At Different Time Windows On Short-term Prognosis Of Patients With Acute Myocardial Infarction
93. Application Value Of Fractional Flow Reserve In The Treatment Of Patients With Intermediate Coronary Stenosis
94. The Outcomes Of Acute Myocardial Infarction Patients Comorbiding With Hypertention And Hyperhomocysteinemia
95. Relation Between Platelet Aggregation Rate And Recent Major Adverse Cardiovascular Events In Patients With Acute Coronary Syndrome
96. The Study Of Predictive Value Of Platelet-to-lymphocyte Ratio Combined With GRACE Score For Cardiovascular Events In Patients With Non-ST-Acute Coronary Syndrome
97. Clinical Study On The Treatment Strategy Of NSTE-ACS Non-culprit Lesions Guided By Intravascular Ultrasound
98. Antiplatelet Efficacy Of P2Y12 Receptor Antagonists In Patients With Different CYP2C19 Genotypes
99. Effect Of Stress Hyperglycemia Ratio On Prognosis In Patients With Acute Coronary Syndrome
100. The Predictive Value Of GNRI In The Severity Of Vascular Lesions And Prognostic Value In Acute St-segment Elevation Myocardial Infarction
  <<First  <Prev  Next>  Last>>  Jump to